loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ciclosporin (S01XA18) - 555806

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ciclosporin (S01XA18) - 555806 has been published on Bidding Source portal dated 20 Sep 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ciclosporin (S01XA18) - 555806
Invitation for Bids
Germany
20 Sep 2024
10 Aug 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient Certolizumab pegol (ATC code according to WHO: L04AB05) - 567111 Germany Medicinal products containing the active substance lipegfilgrastim (ATC: L03AA14) - 566418 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient pomalidomide (ATC code according to WHO: L04AX06) - 565568 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient trastuzumab (ATC: L01FD01). - 554203 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient clobetasol (D07AD01) within the framework of a so-called open-house model. - 556539 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient vaginal ring with gestagens and estrogens (G02BB01) within the framework of a so-called open-house model. - 557740 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient certolizumab pegol (ATC code according to WHO: L04AB05) - 555153 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient olanzapine (N05AH03), without solid oral dosage forms, within the framework of a so-called open-house model. - 558568 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 554035 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient filgrastim (L03AA02) within the framework of a so-called open-house model. - 557104 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans